Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial

Overview of attention for article published in BMC Cancer, December 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 8 X users

wikipedia: 1 Wikipedia page

Readers on

mendeley: 29 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 10,986 followers.

Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial https://t.co/xePIK8Uxgc #hvhebron #onco [Text complet] @BMC_series

RT @schoffski: We have focused a lot on the quantity of life in GIST patients over the past 22 years, and now we finally see prospective qu…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.